These final results, together with a prior report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,two aid the concept of targeting ACKR3 as a novel strategy to modulate the opioid system, which could open new therapeutic avenues for opioid-linked disorders. Title your collection: Name needs https://neilr627iyo2.bcbloggers.com/profile